XPH Stock Summary and Trading Ideas (State Street SPDR S&P Pharmaceuticals ETF | ARCA:XPH)

The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ).

State Street SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.

As of December 24, 2025, XPH stock price climbed to $57.56 with 24,185 million shares trading.

XPH has a beta of 0.72, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.38 to the broad based SPY ETF.

XPH has a market cap of $233.13 million. This is considered a Small Cap stock.

In the last 3 years, XPH traded as high as $57.58 and as low as $34.67.

XPH has outperformed the market in the last year with a price return of +33.7% while the SPY ETF gained +17.3%. XPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +23.4% and +3.1%, respectively, while the SPY returned +4.4% and +1.4%, respectively.

XPH support price is $55.79 and resistance is $57.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH shares will trade within this expected range on the day.